As of January 2026 Regencell Bioscience has a market cap of A$17.74 Billion. This makes Regencell Bioscience the world's 1712th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 30th, 2026 the market cap of Regencell Bioscience was reported to be: